BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DNA fingerprint
,
Clofibrate
,
rs2230926
,
MDM2
,
calcium channel activity
,
Hepatitis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
gefitinib
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
XIST
PLAC8
CLIC3
SERPINA3
LCN2
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
organic cyclic compound binding
heterocyclic compound binding
organic cyclic compound metabolic process
heterocycle metabolic process
PUJANA_BRCA1_PCC_NETWORK
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Breast cancer (ER+) combined therapy treatments associated with clinical responses
Gefitinib induced gene expression in a resistant lung cancer cell line
Acute myeloid leukemia primary cells and cell lines treated with Iressa
Lung adenocarcinoma gefitinib-resistant (PC9/gef) and gefitinib-sensitive (PC9) cell lines
Non-small cell lung cancer HCC827 and PC-9 cells with mutant EGFR treated with gefitinib
Explore Curated Studies Results
Literature
Most Relevant Literature
Gefitinib induces anoikis in cervical cancer cells.
Potential roles of tumor microenvironment in gefitinib-resistant non-small cell lung cancer: A narra…
Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression.
Amelioration of the therapeutic potential of gefitinib against breast cancer using nanostructured li…
Gefitinib-induced Myositis: A Novel Case Report.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Randomized Gefitinib Trial
Third-line Treatment of Gefitinib in NSCLC Patients
Gefitinib Combined With Thalidomide to Treat NSCLC
S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced No…
Hydroxychloroquine and Gefitinib to Treat Lung Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ